Certified by Founder Lodge
Genialis
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $13,000,000
0 Participating Investments
-
Founded date
2015
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Genialis is a computational precision medicines company unraveling complex biology to find new ways to address disease. Our mission is to deliver benefit and hope to patients and their famili
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 30 ,2023 | Series A | $13,000,000 |
Redalpine
Taiwania Capital
First Star Ventures
Debiopharm
P5 Health Ventures
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
